UPDATE: Heron Therapeutics Announces Results from Phase 3 MAGIC Study of SUSTOL: Says Primary Endpoint Achieved
May 28, 2015 at 16:08 PM EDT
Heron Therapeutics, Inc. (NASDAQ: HRTX) today announced positive, top-line results from its recently completed Phase 3 MAGIC study. ...